|
1
|
Zouvelou V, Rentzos M, Toulas P and
Evdokimidis I: AchR-positive myasthenia gravis with MRI evidence of
early muscle atrophy. J Clin Neurosci. 19:918–919. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McGrogan A, Sneddon S and de Vries CS: The
incidence of myasthenia gravis: a systematic literature review.
Neuroepidemiology. 34:171–183. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Giraud M, Vandiedonck C and Garchon HJ:
Genetic factors in autoimmune myasthenia gravis. Ann NY Acad Sci.
1132:180–192. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cavalcante P, Barberis M, Cannone M, et
al: Detection of poliovirus-infected macrophages in thymus of
patients with myasthenia gravis. Neurology. 74:1118–1126. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stefansson K, Dieperink ME, Richman DP and
Marton LS: Sharing of epitopes by bacteria and the nicotinic
acetylcholine receptor: a possible role in the pathogenesis of
myasthenia gravis. Ann NY Acad Sci. 505:451–460. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mantegazza R, Bonanno S, Camera G and
Antozzi C: Current and emerging therapies for the treatment of
myasthenia gravis. Neuropsychiatr Dis Treat. 7:151–160. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tüzün E, Huda R and Christadoss P:
Complement and cytokine based therapeutic strategies in myasthenia
gravis. J Autoimmun. 37:136–143. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chien PJ, Yeh JH, Chiu HC, Hsueh YM, Chen
CT, Chen MC and Shih CM: Inhibition of peripheral blood natural
killer cell cytotoxicity in patients with myasthenia gravis treated
with plasmapheresis. Eur J Neurol. 18:1350–1357. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Osserman KE: Myasthenia gravis. Grune
& Stratton Group; New York, NY: 1958
|
|
10
|
Padua L, Galassi G, Ariatti A, et al:
Myasthenia gravis self-administered questionnaire: development of
regional domains. Neurol Sci. 25:331–336. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang X, Yang M, Xu J, Zhang M, Lang B,
Wang W and Vincent A: Clinical and serological study of myasthenia
gravis in HuBei Province, China. J Neurol Neurosurg Psychiatry.
78:386–390. 2007. View Article : Google Scholar
|
|
12
|
Meriggioli MN and Sanders DB: Autoimmune
myasthenia gravis: emerging clinical and biological heterogeneity.
Lancet Neurol. 8:475–490. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shinomiya N, Nomura Y and Segawa M: A
variant of childhood-onset myasthenia gravis: HLA typing and
clinical characteristics in Japan. Clin Immunol. 110:154–158. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Spalek P, Schnorrer M and Cibulcík F:
Simultaneous occurrence of acute myasthenia gravis and acute
polymyositis in 3 patients and in 2 patients also associated with a
thymoma. Rozhl Chir. 79:468–470. 2000.
|
|
15
|
Tanwani LK, Lohano V, Ewart R, Broadstone
VL and Mokshagundam SP: Myasthenia gravis in conjunction with
Graves’ disease: a diagnostic challenge. Endocr Pract. 7:275–278.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koves IH, Cameron FJ and Kornberg AJ:
Ocular myasthenia gravis and Graves disease in a 10-year-old child.
J Child Neurol. 24:615–617. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yoshikawa H, Satoh K, Yasukawa Y and
Yamada M: Analysis of immunoglobulin secretion by lymph organs with
myasthenia gravis. Acta Neurol Scand. 103:53–58. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kupersmith MJ: Ocular myasthenia gravis:
treatment successes and failures in patients with long-term
follow-up. J Neurol. 256:1314–1320. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
García-Carrasco M, Escárcega RO,
Fuentes-Alexandro S, Riebeling C and Cervera R: Therapeutic options
in autoimmune myasthenia gravis. Autoimmun Rev. 6:373–378. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
van Sonderen A, Wirtz PW, Verschuuren JJ
and Titulaer MJ: Paraneoplastic syndromes of the neuromuscular
junction: therapeutic options in myasthenia gravis, Lambert-Eaton
myasthenic syndrome, and neuromyotonia. Curr Treat Options Neurol.
15:224–39. 2013. View Article : Google Scholar
|
|
21
|
Yu L, Zhang XJ, Ma S, Li F and Zhang YF:
Thoracoscopic thymectomy for myasthenia gravis with and without
thymoma: a single-center experience. Ann Thorac Surg. 93:240–244.
2012. View Article : Google Scholar
|
